A Negative Regulatory Element Controls mRNA Abundance of the Leishmania mexicana Paraflagellar Rod Gene PFR2†

por Mishra, Krishna K., Holzer, Timothy R., Moore, Landon L., LeBowitz, Jonathan H.
Publicado 2003

Coordinate regulation of a family of promastigote-enriched mRNAs by the 3′UTR PRE element in Leishmania mexicana

por Holzer, Timothy R., Mishra, Krishna K., LeBowitz, Jonathan H., Forney, James D.
Publicado 2007

Differential expression of VEGFR2 protein in HER2 positive primary human breast cancer: potential relevance to anti-angiogenic therapies

por Nasir, Aejaz, Holzer, Timothy R., Chen, Mia, Man, Michael Z., Schade, Andrew E.
Publicado en Cancer Cell Int (2017)

Variability in Platelet-Derived Growth Factor Receptor Alpha Antibody Specificity May Impact Clinical Utility of Immunohistochemistry Assays

por Holzer, Timothy R., O’Neill Reising, Leslie, Credille, Kelly M., Schade, Andrew E., Oakley, Gerard J.
Publicado en J Histochem Cytochem (2016)

Analysis of Immune Checkpoint Drug Targets and Tumor Proteotypes in Non-Small Cell Lung Cancer

por Liebler, Daniel C., Holzer, Timothy R., Haragan, Alexander, Morrison, Ryan D., O’Neill Reising, Leslie, Ackermann, Bradley L., Fill, Jeff A., Schade, Andrew E., Gruver, Aaron M.
Publicado en Sci Rep (2020)

A Phase 1 Dose-Escalation, Pharmacokinetic, and Pharmacodynamic Evaluation of eIF-4E Antisense Oligonucleotide LY2275796 in Patients with Advanced Cancer

por Hong, David S., Kurzrock, Razelle, Oh, Yun, Wheler, Jennifer, Naing, Aung, Brail, Les, Callies, Sophie, André, Valérie, Kadam, Sunil K, Nasir, Aejaz, Holzer, Timothy R., Meric-Bernstam, Funda, Fishman, Mayer, Simon, George
Publicado en Clin Cancer Res (2011)

Phase 1 study of narnatumab, an anti-RON receptor monoclonal antibody, in patients with advanced solid tumors

por LoRusso, Patricia M., Gounder, Mrinal, Jalal, Shadia I., André, Valérie, Kambhampati, Siva Rama Prasad, Loizos, Nick, Hall, Jennifer, Holzer, Timothy R., Nasir, Aejaz, Cosaert, Jan, Kauh, John, Chiorean, E. Gabriela
Publicado en Invest New Drugs (2017)

Tumor Cell Expression of Vascular Endothelial Growth Factor Receptor 2 Is an Adverse Prognostic Factor in Patients with Squamous Cell Carcinoma of the Lung

por Holzer, Timothy R., Fulford, Angie D., Nedderman, Drew M., Umberger, Tara S., Hozak, Rebecca R., Joshi, Adarsh, Melemed, Symantha A., Benjamin, Laura E., Plowman, Gregory D., Schade, Andrew E., Ackermann, Bradley L., Konrad, Robert J., Nasir, Aejaz
Publicado 2013

Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial

por Gottlieb, Robert L., Nirula, Ajay, Chen, Peter, Boscia, Joseph, Heller, Barry, Morris, Jason, Huhn, Gregory, Cardona, Jose, Mocherla, Bharat, Stosor, Valentina, Shawa, Imad, Kumar, Princy, Adams, Andrew C., Van Naarden, Jacob, Custer, Kenneth L., Durante, Michael, Oakley, Gerard, Schade, Andrew E., Holzer, Timothy R., Ebert, Philip J., Higgs, Richard E., Kallewaard, Nicole L., Sabo, Janelle, Patel, Dipak R., Klekotka, Paul, Shen, Lei, Skovronsky, Daniel M.
Publicado en JAMA (2021)

Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19

por Dougan, Michael, Nirula, Ajay, Azizad, Masoud, Mocherla, Bharat, Gottlieb, Robert L., Chen, Peter, Hebert, Corey, Perry, Russell, Boscia, Joseph, Heller, Barry, Morris, Jason, Crystal, Chad, Igbinadolor, Awawu, Huhn, Gregory, Cardona, Jose, Shawa, Imad, Kumar, Princy, Adams, Andrew C., Van Naarden, Jacob, Custer, Kenneth L., Durante, Michael, Oakley, Gerard, Schade, Andrew E., Holzer, Timothy R., Ebert, Philip J., Higgs, Richard E., Kallewaard, Nicole L., Sabo, Janelle, Patel, Dipak R., Dabora, Matan C., Klekotka, Paul, Shen, Lei, Skovronsky, Daniel M.
Publicado en N Engl J Med (2021)